S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

EYPT EyePoint Pharmaceuticals Inc

6.28

0.01 (0.16%)

12 Feb 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 12 February 2025 (6 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 12 February 2025 (6 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 5 February 2025 (7 days ago) • Edgar (US Regulatory)

EyePoint Announces Positive Six-Month Results for the Phase 2 VERONA Clinical Trial of DURAVYU™ for Diabetic Macular Edema Meeting Primary and Secondary Endpoints
Wednesday 5 February 2025 (7 days ago) • GlobeNewswire Inc.

EyePoint to Present at Guggenheim SMID Cap Biotech Conference
Thursday 30 January 2025 (2 weeks ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Thursday 16 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (4 weeks ago) • Edgar (US Regulatory)

EyePoint Provides Company Update and Anticipated Development Milestones for 2025
Monday 13 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 9 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 9 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors
Wednesday 8 January 2025 (1 month ago) • GlobeNewswire Inc.

More EyePoint Pharmaceuticals Inc News Articles

Invesco QQQ Trust Series 1

S&P ASX 300 Metals and M...

Westpac Banking

JP Morgan Chase

Verizon Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions